Abstract
Little information is available regarding how body fatness and cardio/respiratory fitness (CRF) are associated with serum vaspin. The purpose of the study was to investigate the combined effect of body mass index (BMI) and CRF on serum vaspin in Korean young men. In a cross-sectional study, we examined 490 Korean young men (mean age 23.8 ± 2.5 years) who were voluntarily recruited. Body fatness and fasting levels of serum insulin, adiponectin, and vaspin were measured. CRF was quantified as the minute volume of oxygen consumption (VO2) measured during a graded treadmill test. We assigned individuals to either low or middle or high third CRF tertiles based on age-adjusted VO2max. We also assigned individuals to either a lean weight (LN) or obese (OB) group based on body fatness levels, in which a BMI value ≥25 kg/m2 was used as an indicator of Pacific-Asian obesity. Group analyses showed significant interaction effects between fatness and CRF on fasting insulin and serum vaspin such that the OB group with low CRF levels had significantly higher insulin and vaspin concentrations than the OB counterparts with moderate to high CRF levels, and no such CRF-based sub-group differences in insulin and vaspin were found in the LN groups. Regression analyses show that BMI, waist circumference, VO2, and fasting insulin explain approximately 18% of the individual variations in serum vaspin concentration in this study population. This is the first study to show that high body fatness along with low CRF might contribute to increased vaspin concentrations in Korean young men.
Similar content being viewed by others
References
Ahima RS, Osei SY (2008) Adipokines in obesity. Front Horm Res 36:182–197
American College of Sports Medicine (2006) ASCM’s guidelines for exercise testing and prescription, 7th edn. Lippinocott Williams & Wilkins, Philadelphia, pp 237–240
Berndt J, Klöting N, Kralisch S, Kovacs P, Fasshauer M, Schön MR, Stumvoll M, Blüher M (2005) Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes 54:2911–2916
Boulé NG, Bouchard C, Tremblay A (2005) Physical fitness and the metabolic syndrome in adults from the Quebec Family Study. Can J Appl Physiol 30:140–156
Bray GA, Champagne CM (2004) Obesity and the metabolic syndrome: implications for dietetics practitioners. J Am Diet Assoc 104:86–89
Carnethon MR, Gidding SS, Nehgme R, Sidney S, Jacobs DR Jr, Liu K (2003) Cardiorespiratory fitness in young adulthood and the development of cardiovascular disease risk factors. JAMA 290:3092–3100
Fried SK, Bunkin DA, Greenberg AS (1998) Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 83:847–850
Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, Matsuki Y, Murakami M, Ichisaka T, Murakami H, Watanabe E, Takagi T, Akiyoshi M, Ohtsubo T, Kihara S, Yamashita S, Makishima M, Funahashi T, Yamanaka S, Hiramatsu R, Matsuzawa Y, Shimomura I (2005) Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307:426–430
Herder C, Baumert J, Thorand B, Koenig W, de Jager W, Meisinger C, Illig T, Martin S, Kolb H (2006) Chemokines as risk factors for type 2 diabetes: results from the MONICA/KORA Augsburg study, 1984–2002. Diabetologia 49:921–929
Hida K, Wada J, Eguchi J, Zhang H, Baba M, Seida A, Hashimoto I, Okada T, Yasuhara A, Nakatsuka A, Shikata K, Hourai S, Futami J, Watanabe E, Matsuki Y, Hiramatsu R, Akagi S, Makino H, Kanwar YS (2005) Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci USA 102:10610–10615
Kempf K, Rose B, Illig T, Rathmann W, Strassburger K, Thorand B, Meisinger C, Wichmann HE, Herder C, Vollmert C (2008) Vaspin (SERPINA12) genotypes and risk of type 2 diabetes: results from the MONICA/KORA studies. Exp Clin Endocrinol Diabetes [Epub ahead of print]. doi:10.1055/s-2008-1081499
Klöting N, Berndt J, Kralisch S, Kovacs P, Fasshauer M, Schön MR, Stumvoll M, Blüher M (2006) Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes. Biochem Biophys Res Commun 339:430–436
Lakka TA, Laaksonen DE, Lakka HM, Männikkö N, Niskanen LK, Rauramaa R, Salonen JT (2003) Sedentary lifestyle, poor cardiorespiratory fitness, and the metabolic syndrome. Med Sci Sports Exerc 35:1279–1286
LaMonte MJ, Ainsworth BE, Durstine JL (2005) Influence of cardiorespiratory fitness on the association between C-reactive protein and metabolic syndrome prevalence in racially diverse women. J Womens Health (Larchmt) 14:233–239
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419
Montague CT, Prins JB, Sanders L, Zhang J, Sewter CP, Digby J, Byrne CD, O’Rahilly S (1998) Depot-related gene expression in human subcutaneous and omental adipocytes. Diabetes 47:1384–1391
Reaven G, Abbasi F, McLaughlin T (2004) Obesity, insulin resistance, and cardiovascular disease. Recent Prog Horm Res 59:207–223
Seeger J, Ziegelmeier M, Bachmann A, Lössner U, Kratzsch J, Blüher M, Stumvoll M, Fasshauer M (2008) Serum levels of the adipokine vaspin in relation to metabolic and renal parameters. J Clin Endocrinol Metab 93:247–251
Suleymanoglu S, Tascilar E, Pirgon O, Tapan S, Meral C, Abaci A (2009) Vaspin and its correlation with insulin sensitivity indices in obese children. Diabetes Res Clin Pract 84:325–328
Tan BK, Heutling D, Chen J, Farhatullah S, Adya R, Keay SD, Kennedy CR, Lehnert H, Randeva HS (2008) Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance. Diabetes 57:1501–1507
Van Harmelen V, Reynisdottir S, Eriksson P, Thörne A, Hoffstedt J, Lönnqvist F, Arner P (1998) Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes 47:913–917
Wareham NJ, Hennings SJ, Byrne CD, Hales CN, Prentice AM, Day NE (1998) A quantitative analysis of the relationship between habitual energy expenditure, fitness and the metabolic cardiovascular syndrome. Br J Nutr 80:235–241
Youn BS, Klöting N, Kratzsch J, Lee N, Park JW, Song ES, Ruschke K, Oberbach A, Fasshauer M, Stumvoll M, Blüher M (2008) Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes 57:372–377
Zhu S, St-Onge MP, Heshka S, Heymsfield SB (2004) Lifestyle behaviors associated with lower risk of having the metabolic syndrome. Metabolism 53:1503–1511
Acknowledgments
This work was supported by a grant funded by the Korean Research Foundation which is funded by the Korean government (MOEHRD) (KRF-2008-321-G00024).
Conflict of interest statement
We have no conflicts of interest to disclose.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by Susan Ward.
Rights and permissions
About this article
Cite this article
Cho, JK., Han, TK. & Kang, HS. Combined effects of body mass index and cardio/respiratory fitness on serum vaspin concentrations in Korean young men. Eur J Appl Physiol 108, 347–353 (2010). https://doi.org/10.1007/s00421-009-1238-8
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00421-009-1238-8